Also see: Ford, GM, Cabot: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.


IHS ( IHS) target boosted at Goldman to $82, according to Goldman Sachs. Company is seeing better organic growth across the board. Neutral rating.

Nike ( NKE - Get Report) estimates, target cut at UBS. NKE estimates were reduced through 2012, UBS said. Company is facing margin pressure. Buy rating and new $90 price target.

Rovi ( ROVI) estimates, target lowered at Morgan Stanley. Shares of ROVI now seen reaching $59. Estimates also cut, to match the company's new guidance. Equal-weight rating.

Sina ( SINA - Get Report) estimates cut at ThinkEquity through 2012. Company is investing more in Weibo. Hold rating and $86 price target.

Staples ( SPLS) target lowered at Goldman to $23. Investor sentiment is getting weaker in the office retail sector. Neutral rating.

United Therapeutics ( UTHR - Get Report) target boosted at JP Morgan to $85. Expect positive data from two ongoing Phase III trials. Overweight rating.

End of report.

This article was written by a staff member of TheStreet.